Tony Wyss-Coray

Overview

Tony Wyss-Coray is presented as a Stanford neurology professor studying how circulating factors, cerebrospinal fluid, and protein signatures relate to brain and organ aging.

Current Profile

In the bounded source, Wyss-Coray connects causal animal experiments with a measurement-and-translation program. His laboratory uses parabiosis and fluid-transfer studies to test whether age- or exercise-associated signals can change old tissues, then uses human proteomics to estimate organ and cell-type aging and future disease risk. He consistently narrows the practical claim: promising mouse results, candidate molecules, plasma fractions, and biological clocks require controlled human studies before becoming therapies or surrogate endpoints.

He also co-founded Vero Biosciences, which is described as applying organ-age signatures alongside clinical and wearable data. This commercial role makes the source informative about intended translation, but it also means performance and utility claims need independent validation.

Key Characteristics

• Studies blood-borne and cerebrospinal-fluid signals as possible drivers as well as markers of aging.
• Uses animal transfer experiments to test causation before proposing human translation.
• Develops proteomic models of organ- and cell-type aging.
• Frames preserved cognition and organ function as more meaningful than lifespan alone.
• Emphasizes blinded, controlled, sufficiently large clinical trials and warns against unproven cell therapies.
• Combines academic research with a disclosed commercial interest in organ-age measurement.

Evidence

• Circulating-factor research: Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray describes young-blood, plasma, exercise-plasma, and cerebrospinal-fluid experiments in mice.
• Measurement program: Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray describes blood-protein models for organ and cell-type age and reported links to future disease risk.
• Translation boundary: Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray repeatedly separates animal or biomarker findings from FDA-supporting clinical evidence.
• Commercial translation: Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray identifies him as a co-founder of Vero Biosciences.

Qualifications

This profile is bounded to one podcast summary and does not independently verify institutional titles, study methods, trial results, company performance, predictive accuracy, regulatory status, or clinical utility. The supplied document alternates among “Wyss-Coray,” “Weiss-Corey,” and related spellings; this page normalizes the guest’s name to Tony Wyss-Coray. Candidate factors, animal effects, disease-risk associations, and product aims are source-scoped rather than treatment guidance.

What Changed

• Created a bounded profile joining circulating-factor experiments, proteomic aging models, and explicit translation limits.
• Recorded the disclosed Vero Biosciences co-founder role as a qualification on commercial claims.

Relationships

• Andrew Huberman - interviewer eliciting mechanism, lifestyle, and clinical-evidence boundaries.
• Huberman Lab - program hosting the bounded discussion.
• Circulating-Factor Aging Biology - principal experimental research frame described in the source.
• Organ-Specific Aging Clock - proteomic measurement program associated with his work.
• Exercise-Conditioned Blood Signaling - exercise-transfer branch of the circulating-factor program.
• Vero Biosciences - company he is reported to have co-founded for organ-age profiling.